Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 1Lymphoid 1

Conditions

Obesity 1Lymphoma, Follicular 1

Interventions

Rituximab 53Cyclophosphamide 50Lenalidomide 41fludarabine 24obinutuzumab 23Prednisone 19Bendamustine Hydrochloride 19Magnetic Resonance Spectroscopy 18Vincristine 17Doxorubicin 16fludarabine phosphate 15Specimen Handling 15zanubrutinib 13Biopsy 12tazemetostat 10ibrutinib 10Whole-Body Irradiation 10pembrolizumab 9Peripheral Blood Stem Cell Transplantation 9venetoclax 8Mycophenolic Acid 7Etoposide 7axicabtagene ciloleucel 6Radiotherapy 6CT-P10 6Therapeutics 5R-CHOP protocol 5tafasitamab 4polatuzumab vedotin 4acalabrutinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Follicular × Fluorescence Polarization Immunoassay × 1 year × Clear all
NCT06114498 2026-01-23

Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction

National Medical Research Center for Therapy and Preventive Medicine

Active not recruiting
240 enrolled
LymphoidOther

Lymphoma, Follicular, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡